Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-004316

CHIEF FINANCIAL OFFICER gave up 282 shares (to pay taxes)

  • CHIEF FINANCIAL OFFICER acquired 991 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ragosa Mark CHIEF FINANCIAL OFFICER 2022-04-26 Option exercise +991 6,639 D
Ragosa Mark CHIEF FINANCIAL OFFICER 2022-04-26 Shares withheld for taxes −282 $9.99 $2,817 6,357 D
Derivatives
Ragosa Mark CHIEF FINANCIAL OFFICER 2022-04-26 Option exercise · Restricted Share Unit −991 2,971 D
Loading xslF345X03/form4-04282022_040401.xml…